CoChat

The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation

Blake, Kevin S., Xue, Yao-Peng, Gillespie, Vincent J., Fishbein, Skye R. S., Tolia, Niraj H., Wencewicz, Timothy A., Dantas, Gautam · 2025 · Nature Communications
Cited by 80

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The history of clinical resistance to tetracycline antibiotics is characterized by cycles whereby the deployment of a new generation of drug molecules is quickly followed by the discovery of a new mechanism of resistance. This suggests mechanism-specific selection by each tetracycline generation; however, the evolutionary dynamics of this remain unclear. Here, we evaluate 24 recombinant Escherichia coli strains expressing tetracycline resistance genes from each mechanism (efflux pumps, ribosomal protection proteins, and enzymatic inactivation) in the context of each tetracycline generation. We employ a high-throughput barcode sequencing protocol that can discriminate between strains in mixed culture and quantify their relative abundances. We find that each mechanism is preferentially selected for by specific antibiotic generations, leading to their expansion. Remarkably, the minimum inhibitory concentration associated with individual genes is secondary to resistance mechanism for inter-mechanism relative fitness, but it does explain intra-mechanism relative fitness. These patterns match the history of clinical deployment of tetracycline drugs and resistance discovery in pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-025-56425-5

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 89

  1. Orr, H. A. Fitness and its role in evolutionary genetics. Nat. Rev. Genet. 10, 531–539 (2009). · DOI · Paper page
  2. Kassen, R. & Rainey, P. B. The ecology and genetics of microbial diversity. Annu. Rev. Microbiol. 58, 207–231 (2004). · DOI · Paper page
  3. Brito, I. L. Examining horizontal gene transfer in microbial communities. Nat. Rev. Microbiol. 19, 442–453 (2021). · DOI · Paper page
  4. Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect. Dis. 19, 56–66 (2019). · DOI · Paper page
  5. Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147–1151 (2016). · DOI · Paper page
  6. Palmer, A. C., Angelino, E. & Kishony, R. Chemical decay of an antibiotic inverts selection for resistance. Nat. Chem. Biol. 6, 105–107 (2010). · DOI · Paper page
  7. Lazar, V. et al. Bacterial evolution of antibiotic hypersensitivity. Mol. Syst. Biol. 9, 700 (2013). · DOI · Paper page
  8. Boolchandani, M., D’Souza, A. W. & Dantas, G. Sequencing-based methods and resources to study antimicrobial resistance. Nat. Rev. Genet. 20, 356–370 (2019).
  9. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775–781 (2000). · DOI · Paper page
  10. Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260–271 (2010). · DOI · Paper page
  11. Wright, P. M., Seiple, I. B. & Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. Angew. Chem. Int. Ed. Engl. 53, 8840–8869 (2014). · DOI · Paper page
  12. Thaker, M., Spanogiannopoulos, P. & Wright, G. D. The tetracycline resistome. Cell Mol. Life Sci. 67, 419–431 (2010). · DOI · Paper page
  13. Jaroszewski, J., Mamun, N. & Czaja, K. Bidirectional interaction between tetracyclines and gut microbiome. Antibiotics 12, 1438 (2023). · DOI
  14. Duggar, B. M. Aureomycin; a product of the continuing search for new antibiotics. Ann. N. Y Acad. Sci. 51, 177–181 (1948). · DOI · Paper page
  15. Finlay, A. C. et al. Terramycin, a new antibiotic. Science 111, 85 (1950). · doi:10.1126/science.111.2874.85.a
  16. Markley, J. L. & Wencewicz, T. A. Tetracycline-inactivating enzymes. Front. Microbiol. 9, 1058 (2018). · DOI · Paper page
  17. Nelson, M. L. & Levy, S. B. The history of the tetracyclines. Ann. N. Y Acad. Sci. 1241, 17–32 (2011). · DOI · Paper page
  18. Greer, N. D. Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc. (Bayl. Univ. Med Cent.) 19, 155–161 (2006).
  19. Arenz, S., Nguyen, F., Beckmann, R. & Wilson, D. N. Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-A resolution. Proc. Natl Acad. Sci. USA 112, 5401–5406 (2015). · DOI · Paper page
  20. Fang, L. X. et al. Emerging high-level tigecycline resistance: novel tetracycline destructases spread via the mobile tet(X). Bioessays 42, e2000014 (2020). · DOI · Paper page
  21. Seifert, H., Blondeau, J. & Dowzicky, M. J. In vitro activity of tigecycline and comparators (2014-2016) among key WHO ‘priority pathogens’ and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study. Int. J. Antimicrob. Agents 52, 474–484 (2018). · DOI
  22. Shakil, S., Akram, M. & Khan, A. U. Tigecycline: a critical update. J. Chemother. 20, 411–419 (2008). · DOI
  23. Deeks, E. D. Sarecycline: first global approval. Drugs 79, 325–329 (2019). · DOI · Paper page
  24. Watanabe, T. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27, 87–115 (1963). · DOI · Paper page
  25. Akiba, T., Koyama, K., Ishiki, Y., Kimura, S. & Fukushima, T. On the mechanism of the development of multiple-drug-resistant clones of Shigella. Jpn J. Microbiol. 4, 219–227 (1960). · DOI · Paper page
  26. Wasteson, Y., Hoie, S. & Roberts, M. C. Characterization of antibiotic resistance in Streptococcus suis. Vet. Microbiol. 41, 41–49 (1994). · DOI
  27. Paulsen, I. T., Brown, M. H. & Skurray, R. A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60, 575–608 (1996). · doi:10.1128/mr.60.4.575-608.1996 · Paper page
  28. Kuck, N. A. & Forbes, M. Uptake of minocycline and tetracycline by tetracycline-susceptible and -resistant bacteria. Antimicrob. Agents Chemother. 3, 662–664 (1973). · DOI
  29. Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299–304 (2017). · DOI · Paper page
  30. Burdett, V. Identification of tetracycline-resistant R-plasmids in Streptococcus agalactiae (group B). Antimicrob. Agents Chemother. 18, 753–760 (1980). · DOI · Paper page
  31. Burdett, V., Inamine, J. & Rajagopalan, S. Heterogeneity of tetracycline resistance determinants in Streptococcus. J. Bacteriol. 149, 995–1004 (1982). · DOI · Paper page
  32. Speer, B. S. & Salyers, A. A. Characterization of a novel tetracycline resistance that functions only in aerobically grown Escherichia coli. J. Bacteriol. 170, 1423–1429 (1988). · DOI
  33. Speer, B. S., Bedzyk, L. & Salyers, A. A. Evidence that a novel tetracycline resistance gene found on two Bacteroides transposons encodes an NADP-requiring oxidoreductase. J. Bacteriol. 173, 176–183 (1991). · DOI · Paper page
  34. Leski, T. A. et al. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone. Int. J. Antimicrob. Agents 42, 83–86 (2013). · doi:10.1016/j.ijantimicag.2013.04.014
  35. Forsberg, K. J., Patel, S., Wencewicz, T. A. & Dantas, G. The tetracycline destructases: a novel family of tetracycline-inactivating enzymes. Chem. Biol. 22, 888–897 (2015). · DOI · Paper page
  36. Park, J. et al. Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes. Nat. Chem. Biol. 13, 730–736 (2017). · DOI
  37. Nguyen, F. et al. Tetracycline antibiotics and resistance mechanisms. Biol. Chem. 395, 559–575 (2014). · DOI · Paper page
  38. Ogunmolu, O., Liu, X., Gans, N. & Wiersma, R. D. Mechanism and model of a soft robot for head stabilization in cancer radiation therapy. IEEE Int. Conf. Robot. Autom. 2020, 4609–4615 (2020).
  39. Li, R. et al. Co-occurrence of two tet(X) variants in an Empedobacter brevis of shrimp origin. Antimicrob. Agents Chemother. 63, e01636–19 (2019). · doi:10.1128/aac.01636-19
  40. Wang, L. et al. Novel plasmid-mediated tet(X5) gene conferring resistance to tigecycline, eravacycline, and omadacycline in a clinical Acinetobacter baumannii isolate. Antimicrob. Agents Chemother. 64, e01326–19 (2019). · DOI · Paper page
  41. Chen, C. et al. Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species. Genome Med. 12, 111 (2020). · DOI
  42. He, D. et al. A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin. J. Antimicrob. Chemother. 75, 1159–1164 (2020). · DOI
  43. Liu, D. et al. Identification of the novel tigecycline resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin. J. Antimicrob. Chemother. 75, 1428–1431 (2020). · doi:10.1093/jac/dkaa037
  44. Gasparrini, A. J. et al. Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance. Commun. Biol. 3, 241 (2020). · DOI · Paper page
  45. Berglund, F. et al. Comprehensive screening of genomic and metagenomic data reveals a large diversity of tetracycline resistance genes. Micro. Genom. 6, mgen000455 (2020).
  46. Blake, K. S. et al. Sequence-structure-function characterization of the emerging tetracycline destructase family of antibiotic resistance enzymes. Commun. Biol. 7, 336 (2024). · DOI
  47. Knapp, C. W., Dolfing, J., Ehlert, P. A. & Graham, D. W. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ. Sci. Technol. 44, 580–587 (2010). · DOI · Paper page
  48. Bryan, A., Shapir, N. & Sadowsky, M. J. Frequency and distribution of tetracycline resistance genes in genetically diverse, nonselected, and nonclinical Escherichia coli strains isolated from diverse human and animal sources. Appl. Environ. Microbiol. 70, 2503–2507 (2004). · DOI · Paper page
  49. He, T. et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat. Microbiol. 4, 1450–1456 (2019). · DOI · Paper page
  50. Crook, N., Ferreiro, A., Condiotte, Z. & Dantas, G. Transcript barcoding illuminates the expression level of synthetic constructs in E. coli Nissle residing in the mammalian gut. ACS Synth. Biol. 9, 1010–1021 (2020). · DOI
  51. Tang, H., Liu, Z., Hu, B. & Zhu, L. D-Ring modifications of tetracyclines determine their ability to induce resistance genes in the environment. Environ. Sci. Technol. 58, 1338–1348 (2024). · DOI
  52. Da Cunha, V. et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat. Commun. 5, 4544 (2014). · DOI · Paper page
  53. Chen, T. et al. The tigecycline resistance gene tetX has an expensive fitness cost based on increased outer membrane permeability and metabolic burden in Escherichia coli. J. Hazard Mater. 458, 131889 (2023). · DOI
  54. Palmer, A. C. & Kishony, R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14, 243–248 (2013). · DOI · Paper page
  55. Chait, R., Vetsigian, K. & Kishony, R. What counters antibiotic resistance in nature? Nat. Chem. Biol. 8, 2–5 (2011). · DOI
  56. Kelsic, E. D., Zhao, J., Vetsigian, K. & Kishony, R. Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature 521, 516–519 (2015). · DOI · Paper page
  57. Sun, J. et al. Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat. Microbiol 4, 1457–1464 (2019). · DOI · Paper page
  58. Shales, S. W., Chopra, I. & Ball, P. R. Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J. Gen. Microbiol. 121, 221–229 (1980).
  59. Bjorkman, J., Nagaev, I., Berg, O. G., Hughes, D. & Andersson, D. I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287, 1479–1482 (2000). · DOI · Paper page
  60. zur Wiesch, P. A., Kouyos, R., Engelstadter, J., Regoes, R. R. & Bonhoeffer, S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 11, 236–247 (2011). · DOI · Paper page
  61. Jiang, L., Cai, W., Tang, F., Wang, Z. & Liu, Y. Characterization of fitness cost caused by tigecycline-resistance gene tet(X6) in different host bacteria. Antibiotics 10, 1172 (2021). · DOI
  62. Tang, F., Cai, W., Jiang, L., Wang, Z. & Liu, Y. Large-scale analysis of fitness cost of tet(X4)-positive plasmids in Escherichia coli. Front. Cell Infect. Microbiol. 12, 798802 (2022). · doi:10.3389/fcimb.2022.798802
  63. Herren, C. M. & Baym, M. Decreased thermal niche breadth as a trade-off of antibiotic resistance. ISME J. 16, 1843–1852 (2022). · DOI
  64. Mueller, E. A., Egan, A. J., Breukink, E., Vollmer, W. & Levin, P. A. Plasticity of Escherichia coli cell wall metabolism promotes fitness and antibiotic resistance across environmental conditions. Elife 8, e40754 (2019). · DOI
  65. Saenger, W., Orth, P., Kisker, C., Hillen, W. & Hinrichs, W. The tetracycline repressor-A paradigm for a biological switch. Angew. Chem. Int Ed. Engl. 39, 2042–2052 (2000). · DOI · Paper page
  66. Orth, P., Schnappinger, D., Hillen, W., Saenger, W. & Hinrichs, W. Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nat. Struct. Biol. 7, 215–219 (2000). · DOI
  67. Stone, L. K. et al. Compounds that select against the tetracycline-resistance efflux pump. Nat. Chem. Biol. 12, 902–904 (2016). · DOI · Paper page
  68. Williford, E. E. et al. Structure-based design of bisubstrate tetracycline destructase inhibitors that block flavin redox cycling. J. Med. Chem. 66, 3917–3933 (2023). · DOI
  69. Markley, J. L. et al. Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes. ACS Infect. Dis. 5, 618–633 (2019). · DOI
  70. Bradford, P. A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933–951 (2001). · DOI · Paper page
  71. Bush, K. Past and Present Perspectives on beta-Lactamases. Antimicrob. Agents Chemother. 62, e01076–18 (2018). · DOI · Paper page
  72. Rice, L. B. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin. Proc. 87, 198–208 (2012). · DOI · Paper page
  73. Palzkill, T. Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC beta-lactamases. Front Mol. Biosci. 5, 16 (2018). · DOI · Paper page
  74. Marciano, D. C., Karkouti, O. Y. & Palzkill, T. A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase. Genetics 176, 2381–2392 (2007). · DOI
  75. Majiduddin, F. K. & Palzkill, T. Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1. Antimicrob. Agents Chemother. 49, 3421–3427 (2005). · DOI
  76. Bush, K. & Bradford, P. A. Epidemiology of beta-lactamase-producing pathogens. Clin. Microbiol. Rev. 33, e00047–19 (2020). · DOI · Paper page
  77. Deng, Z. et al. Deep sequencing of systematic combinatorial libraries reveals beta-lactamase sequence constraints at high resolution. J. Mol. Biol. 424, 150–167 (2012). · DOI · Paper page
  78. Lu, S. et al. Mutagenesis and structural analysis reveal the CTX-M beta-lactamase active site is optimized for cephalosporin catalysis and drug resistance. J. Biol. Chem. 299, 104630 (2023). · doi:10.1016/j.jbc.2023.104630
  79. Judge, A. et al. Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M beta-lactamase. Commun. Biol. 6, 35 (2023). · DOI
  80. Judge, A. et al. Network of epistatic interactions in an enzyme active site revealed by large-scale deep mutational scanning. Proc. Natl Acad. Sci. USA 121, e2313513121 (2024). · DOI · Paper page
  81. Jacquier, H. et al. Capturing the mutational landscape of the beta-lactamase TEM-1. Proc. Natl Acad. Sci. USA 110, 13067–13072 (2013). · DOI · Paper page
  82. Linkevicius, M., Sandegren, L. & Andersson, D. I. Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob. Agents Chemother. 60, 789–796 (2016). · DOI · Paper page
  83. Novais, A. et al. Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog. 6, e1000735 (2010). · DOI
  84. Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203–1210 (1997). · DOI · Paper page
  85. Huerta-Cepas, J., Serra, F. & Bork, P. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol. Biol. Evol. 33, 1635–1638 (2016). · DOI · Paper page
  86. Sohngen, C., Bunk, B., Podstawka, A., Gleim, D. & Overmann, J. BacDive-the bacterial diversity metadatabase. Nucleic Acids Res 42, D592–D599 (2014). · doi:10.1093/nar/gkt1058
  87. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 12th edition (Clinical and Laboratory Standards Institute, 2018).
  88. Feldgarden, M. et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci. Rep. 11, 12728 (2021). · DOI · Paper page
  89. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014). · DOI · Paper page

Cited by

See all 80

Metadata

Authors
Blake, K. S., Xue, Y.-P., Gillespie, V. J., Fishbein, S. R. S., Tolia, N. H., Wencewicz, T. A., & Dantas, G.
Venue
Nature Communications
Published
2025-02-07
Volume
16
Issue
1
ISSN
2041-1723
Cited by
80
References
12
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007130)
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (2U01AI123394)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. https://app.cochat.ai/papers/10.1038/s41467-025-56425-5
The paper
Blake, K. S., Xue, Y.-P., Gillespie, V. J., Fishbein, S. R. S., Tolia, N. H., Wencewicz, T. A., & Dantas, G. (2025). The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. Nature Communications. https://doi.org/10.1038/s41467-025-56425-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.